共 11 条
- [2] Trials in type 1 diabetes: Antigen-specific therapies [J]. CLINICAL IMMUNOLOGY, 2013, 149 (03) : 345 - 355
- [3] Rational development of antigen-specific therapies for type 1 diabetes [J]. IMMUNE-MEDIATED DISEASES: FROM THEORY TO THERAPY, 2007, 601 : 313 - 319
- [6] IMMUNOLOGY AND DIABETES WORKSHOPS - REPORT OF THE 1ST INTERNATIONAL WORKSHOP ON THE STANDARDIZATION OF CYTOPLASMIC ISLET CELL ANTIBODIES - SUMMARY OF A WORKSHOP ORGANIZED BY THE JUVENILE-DIABETES-FOUNDATION-INTERNATIONAL HELD IN MONTE-CARLO ON 31 OCTOBER AND 1 NOVEMBER 1985 [J]. DIABETOLOGIA, 1986, 29 (02) : 125 - 126
- [9] IMMUNOLOGY AND DIABETES WORKSHOPS - REPORT OF THE 2ND INTERNATIONAL WORKSHOP ON THE STANDARDIZATION OF CYTOPLASMIC ISLET CELL ANTIBODIES - SUMMARY OF A WORKSHOP ORGANIZED BY THE IMMUNOLOGY-AND-DIABETES-WORKSHOPS-COMMITTEE, SUPPORTED IN PART BY THE JUVENILE-DIABETES-FOUNDATION-INTERNATIONAL, AND HELD AT THE SCIENCE AT SEA-1987 MEETING IN PERTH, WESTERN-AUSTRALIA, FROM 20-22 JANUARY 1987T [J]. DIABETOLOGIA, 1987, 30 (04) : 273 - 273
- [10] Combination Treatment with Antigen-Specific Dual-Sized Microparticle System Plus Anti-CD3 Immunotherapy Fails to Synergize to Improve Late-Stage Type 1 Diabetes Prevention in Nonobese Diabetic Mice [J]. ACS BIOMATERIALS SCIENCE & ENGINEERING, 2020, 6 (10): : 5941 - 5958